More than 34 million Americans have diabetes. And approximately 90-95% of them have type 2 diabetes. The Food and Drug Administration has sounded the alarm and recalled the diabetes drug metformin hydrcholoride, saying it has high levels of a cancer-causing agent.
Marksans Pharma Limited manufactures the drug. The recalled drug is the “extended-release tablets” under the brand name Time-Cap Labs, Inc. The recall applies to tablets between 500 mg and 750 mg. The drug lowers blood glucose levels in type 2 diabetes patients.
In tests, Marksana Pharma found the drug contained an unacceptably high level of Nitrosodimethylamine, which is considered a probable human carcinogen. The FDA is still investigating where NDMA comes from and how it ends up in metformin products.